Latest News
- Driving down drug prices: how regulators can influence affordability Published: 2017-05-03
- EMA adopts new guidance on monitoring of biologicals Published: 2017-04-28
- Sandoz plans to launch five more biosimilars by 2020 Published: 2017-04-26
- The satisfaction of healthcare payers, patients and physicians with generic imatinib Published: 2017-04-24
- Pure red cell aplasia in a CKD patient after treatment with epoetin zeta Published: 2017-04-21
Most Read Articles
-
A review of generic medicine pricing in Europe
Review Article | Volume 1 / Year 2012 / Issue 1 -
The generic pharmaceutical industry: moving beyond incremental innovation towards re-innovation
Original Research | Volume 2 / Year 2013 / Issue 1 -
National and regional activities by sickness funds in Austria to encourage the rational use of medicines
Editorial | Volume 2 / Year 2013 / Issue 2 -
Biosimilars patent litigation in the EU and the US: a comparative strategic overview
Review Article | Volume 4 / Year 2015 / Issue 3 -
Biosimilars versus ‘biobetters’—a regulator’s perspective
Commentary | Volume 3 / Year 2014 / Issue 4
-
A review of generic medicine pricing in Europe
Important Journal Links